ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union. The company offers Trichomylin, a softgel capsules with fixed…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Transactions 2026-05-29 Financing
ZYUS Life Sciences Corporation Announces Material Change Related to Secured Loan Financing and Anticipated Delay in Filing Financial Statements
Material change report - English.pdf
Transactions 2026-05-28 Financing
ZYUS Life Sciences Corporation Announces Closing of Second Tranche of Secured Loan Financing and Provides an Update on its Annual Filings and Q1 2026 Financial Statement
News release - English.pdf
Transactions 2026-05-21 Financing
ZYUS Life Sciences Corporation Announces Closing of First Tranche of Secured Loan Financing and Provides an Update on its Annual Filings
News release - English.pdf
News 2026-05-05
ZYUS Life Sciences Expands U.S. Patent Portfolio with Second Pain Management Patent
News release - English.pdf
News 2026-04-16
ZYUS Life Sciences Announces Completion of the Final Study Visit by the Last Patient in Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug
News release - English.pdf
Transactions 2026-04-11 Financing
ZYUS Life Sciences Provides an Update on Its Unit Offering
News release - English.pdf
Transactions 2026-04-10 Financing
Report of exempt distribution (45-106F1).pdf
Transactions 2026-03-31 Financing
ZYUS Life Sciences Corporation Announces Material Change Report
Material change report - English.pdf
Transactions 2026-03-31 Financing
ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering
Material change report - English.pdf
Transactions 2026-03-20 Financing
ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering
News release - English.pdf
Transactions 2026-03-17
Material document(s).pdf
Transactions 2026-03-17 Financing
ZYUS Life Sciences Corporation Closes C$0.5 Million Unsecured Promissory Note Financing
Material change report - English.pdf
Transactions 2026-03-05 Financing
ZYUS Life Sciences Announces Closing of Debt Financing
News release - English.pdf
Transactions 2026-03-05 Financing
ZYUS Life Sciences Corporation Announces Cancellation of Brokered Private Placement, Intention to Solicit Non-Brokered Private Placement, and Amendment to Loan Agreement
Material change report - English.pdf
Transactions 2026-03-05
Material document(s).pdf
Transactions 2026-02-25 Financing
ZYUS Life Sciences Announces Cancellation of LIFE Offering and Launch of Private Placement
News release - English.pdf
Transactions 2026-02-12 Financing
ZYUS Life Sciences Corporation Announces Amendment to Subleases and Promissory Note Agreement, and Amendment to Offering Document for LIFE Offering
Material change report - English.pdf
News 2026-02-09
Offering document (amended) - English.pdf
Transactions 2026-02-09 Financing
ZYUS Life Sciences Announces Filing of Amended and Restated LIFE Offering Document
News release - English.pdf
Transactions 2026-02-05 Financing
ZYUS Life Sciences Announces Amendment to Subleases and Promissory Note Agreement
News release - English.pdf
News 2026-01-12
Offering document - English.pdf
Transactions 2026-01-12 Financing
ZYUS Life Sciences Announces LIFE Offering of a minimum of C$15 Million and maximum of C$16 Million of Units
News release - English.pdf
Results 2026-01-08
ZYUS Life Sciences Reports Preliminary Results from Ongoing Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug
News release - English.pdf
News 2025-12-08
ZYUS Life Sciences Provides Update on Clinical Trial Progress and Unit Private Placement
News release - English.pdf
Results 2025-11-26 Financials
Interim MD&A - English.pdf
Results 2025-11-26 Financials
Interim financial statements/report – English.pdf
News 2025-11-13
Report of exempt distribution (45-106F1).pdf
News 2025-11-07
News release - English.pdf
Transactions 2025-10-29
Other material contracts - English.pdf
Transactions 2025-10-29
Other material contracts - English.pdf
Transactions 2025-10-29
Other material contracts - English.pdf
News 2025-10-21
Material change report - English.pdf
News 2025-10-20
News release - English.pdf
News 2025-10-17
News release - English.pdf
News 2025-10-17
News release - English.pdf
News 2025-10-17
Early warning report.pdf
News 2025-10-17
Early warning report.pdf
News 2025-10-17
News release - English.pdf
News 2025-10-02
News release - English.pdf
Results 2025-08-28 Financials
Interim MD&A - English.pdf
Results 2025-08-28 Financials
Interim financial statements/report – English.pdf
News 2025-08-26
News release - English.pdf
News 2025-08-20
Report of exempt distribution (45-106F1).pdf
News 2025-08-16
News release - English.pdf
News 2025-08-06
Report of exempt distribution (45-106F1).pdf
News 2025-07-30
News release - English.pdf
News 2025-07-15
Material change report - English.pdf
News 2025-07-15
News release - English.pdf
News 2025-07-03
Report of exempt distribution (45-106F1).pdf
News 2025-06-30
Material change report - English.pdf
News 2025-06-30
Early warning report.pdf
News 2025-06-28
News release - English.pdf
News 2025-06-27
News release - English.pdf
News 2025-06-24
Report of exempt distribution (45-106F1).pdf
News 2025-06-17
News release - English.pdf